Although the proportion of the deletion is relatively small, all symptoms—profound ID, absence of speech, epilepsy, microcephaly, growth retardation, and dysmorphic features—are similar to those described in 21q22.12q22.2-deletions which includes DYRK1A (Figure S1F). This evidence concerns the gene DYRK1A and microcephaly.